Grants aim to support projects and initiatives from healthcare stakeholders to improve healthcare and/or advance scientific/medical knowledge, consistent with Novo Nordisk’s purpose; they are provided freely without the intent of receiving any benefit in exchange.
Projects/initiatives can be related to medical/scientific activities, healthcare education, policy initiatives, patient engagement related activities, and healthcare system strengthening.
We consider grants to legitimate UK organisations for activities that:
- Directly benefit patients, improve patient care, or strengthen healthcare systems (e.g., service improvements, patient education, pathway innovations)
- Advance independent medical/scientific education or quality improvement
- Support policy, advocacy, and community engagement that help address access and health equality
- Relate to the following therapy areas: diabetes, obesity, cardiovascular disease and rare blood disorders
We are unable to provide grants:
- For projects/initiatives that have already started or completed
- To individuals
- Where the request for and purpose of the project/initiative is linked to a medicine
- That offset any normal operating expense not directly tied to the project/initiative, for example core operating costs such as routine utilities, office supplies, rent, maintenance, salaries/wages, or general overheads
Support in the form of a financial contribution for individuals to:
- Attend meetings and events or training courses
- Undertake Research Fellowships
Clinical research associated with Novo Nordisk products, including Investigator Sponsored Studies
Sponsorship of scientific meetings, events, or congresses
Collaborative Working projects
Please use the following link to access Novo Nordisk’s External Support System website. Initial registration is required before an application can be submitted: Login to portal
All applications are reviewed by the Novo Nordisk Grant Panel; applicants will be notified of the Panel’s decision within 6–8 weeks of submission.